Month of Review |
Medication Use |
Date for PhRMA Submission |
Alaska Medicaid
P&T Meeting |
New classes for review are noted with an asterisk. |
September 2008 |
|
August 22,
2008 |
September 26,
2008 |
LMW Heparins |
Blood Thinner |
|
|
Hematopoietic Agents |
Anemia |
|
|
Electrolyte Depleters |
Renal Disease |
|
|
Bisphosphonates |
Osteoporosis |
|
|
Androgen Hormone Inhibitors |
Prostate |
|
|
Alpha Blockers |
Prostate and high blood pressure |
|
|
Alzheimer’s Drugs |
Alzheimer’s Disease |
|
|
MS drugs |
Multiple Sclerosis |
|
|
Parkinson Drugs |
Parkinson’s Disease |
|
|
Anti-TNF Drugs |
Rheumatoid Arthritis Drugs |
|
|
Statins |
Cholesterol Medications |
|
|
Fibric Acid Derivatives |
Cholesterol Medications |
|
|
Niacins |
Cholesterol Medications |
|
|
* Bile Acid Sequestrants |
Cholesterol Medications |
|
|
* Endothelial Receptor Antagonists |
Pulmonary Hypertension |
|
|
* Topical Agents for Psoriasis |
Psoriasis |
|
|
* Calcitonins |
Osteoporosis |
|
|
* Platelet Inhibitors |
Blood Thinner |
|
|
|
Month of Review |
Medication Use |
Date for PhRMA Submission |
Alaska Medicaid
P&T Meeting |
New classes for review are noted with an asterisk. |
November 2008 |
|
October 10, 2008 |
November 14, 2008 |
*Atypical Antipsychotics |
|
|
|
Growth Hormone |
Growth Hormone |
|
|
SSRI |
Antidepressant |
|
|
SNRI |
Antidepressant |
|
|
Other Antidepressants |
Antidepressant |
|
|
Sedative Hypnotics |
Sleeping Aid |
|
|
ADD/ADHD |
Attention Deficit Disorder |
|
|
Anticonvulsants,
1st Generation |
Anti-seizure |
|
|
Anticonvulsants,
2nd Generation |
Anti-seizure |
|
|
Long Acting Opioids |
Pain |
|
|
Fentanyl, buccal |
Pain |
|
|
PPIs |
Anti-ulcer |
|
|
H2RA |
Anti-ulcer |
|
|
Urinary Tract Antispasmodics |
Urinary Incontinence |
|
|
COX-2 Inhibitor |
Arthritis |
|
|
|
Month of Review |
Medication Use |
Date for PhRMA Submission |
Alaska Medicaid
P&T Meeting |
New classes for review are noted with an asterisk. |
January 2009 |
|
December 12, 2008 |
January 16, 2009 |
| Benzoyl Peroxide / Clindamycin Combos |
Acne |
|
|
Renin Inhibitors |
High Blood Pressure |
|
|
ACE |
High Blood Pressure |
|
|
ARB |
High Blood Pressure |
|
|
CCB |
High Blood Pressure |
|
|
Topical Iimmunomodulators |
Skin Rash |
|
|
Oral Beta Blockers |
Heart and Blood Pressure |
|
|
Sulfonylureas |
Diabetes |
|
|
Insulins |
Diabetes |
|
|
TZDs |
Diabetes |
|
|
Biguanides |
Diabetes |
|
|
Metglinides |
Diabetes |
|
|
Incretin Mimetics |
Diabetes |
|
|
Alpha Glucosidase Inhibitor |
Diabetes |
|
|
Glaucoma Agents |
Glaucoma |
|
|
* Ulcerative Colitis |
Colitis |
|
|
* Testosterone Topical |
Hormone
Replacement |
|
|
* Topical Retinoids |
Acne |
|
|
* Immunosuppressants |
Anti-rejection medications for transplants |
|
|
|
Month of Review |
Medication Use |
Date for PhRMA Submission |
Alaska Medicaid
P&T Meeting |
New classes for review are noted with an asterisk. |
April 2009 |
|
March 13, 2009 |
April 17, 2009 |
Low-sedating Antihistamines |
Anti-allergy |
|
|
Otic Quinolones |
Antibiotics for ears |
|
|
Anti-emetic |
Anti-nauseant |
|
|
Anti-migraine |
Anti-migraine |
|
|
Nasal Steroids |
Anti-allergy |
|
|
Leukotriene Inhibitors |
Asthma |
|
|
Inhaled Steroids |
Asthma |
|
|
Short Acting Beta Agonists |
Asthma |
|
|
Long Acting Beta Agonists |
Asthma |
|
|
COPD Inhalant Drugs |
COPD |
|
|
2nd & 3rd Generation Cephlasporins |
Antibiotics |
|
|
2nd & 3rd Generation Quinolones |
Antibiotics |
|
|
Ophthalmic Anti-allergy
Agents |
Anti-allergy for eyes |
|
|
Ophthalmic Mast Cell Stablizers |
Anti-allergy for eyes |
|
|
Ophthalmic Quinolones |
Antibiotics for the eyes |
|
|
Ophthalmic
Immunomodulator |
Dry eyes |
|
|
Hepatitis C |
Hepatitis C Medications |
|
|
Anti-herpes
Oral Medication |
Genital Herpes, Shingles |
|
|
Anti-fungal – Onychomycosis |
Nail Fungus |
|
|
Macrolides |
Oral Antibiotic |
|
|
* Topical Antiviral |
Genital Herpes, Shingles |
|
|
* Ophthalmic NSAIDS |
Ophthalmic Inflammation |
|
|
|
|
|
Month of Review |
Medication Use |
Date for PhRMA Submission |
Alaska Medicaid
P&T Meeting |
All classes are being re-reviewed unless noted with an asterisk * |
September 2007 |
|
August 20, 2007 |
September 28, 2007 |
* LMW Heparins |
Blood thinner |
|
|
* Hematopoietic Agents |
Anemia |
|
|
Electrolyte Depleters |
Renal Disease |
|
|
Bisphosphonates |
Osteoporosis |
|
|
Androgen Hormone Inhibitors |
Prostate |
|
|
Alpha Blockers |
Prostate and high blood pressure |
|
|
Alzheimer’s Drugs |
Alzheimer’s Disease |
|
|
MS drugs |
Multiple Sclerosis |
|
|
Parkinson Drugs |
Parkinson’s Disease |
|
|
Anti-TNF Drugs |
Rheumatoid Arthritis Drugs |
|
|
Statins |
Cholesterol Medications |
|
|
Fibric Acid Derivatives |
Cholesterol Medications |
|
|
Niacins |
Cholesterol Medications |
|
|
Macrolides |
Oral Antibiotic |
|
|
|
Month of Review |
Medication Use |
Date for PhRMA Submission |
Alaska Medicaid
P&T Meeting |
All classes are being re-reviewed unless noted with an asterisk * |
November 2007 |
|
October 8, 2007 |
November 16, 2007 |
* Growth Hormone |
Growth Hormone |
|
|
SSRI |
Antidepressant |
|
|
SNRI |
Antidepressant |
|
|
Other Antidepressants |
Antidepressant |
|
|
Sedative Hypnotics |
Sleeping |
|
|
ADD/ADHD |
Attention Deficit Disorder |
|
|
Anticonvulsants,
1st Generation |
Anti-seizure |
|
|
Anticonvulsants,
2nd Generation |
Anti-seizure |
|
|
Long Acting Opioids |
Pain |
|
|
* Fentanyl, buccal |
Pain |
|
|
PPIs |
Anti-ulcer |
|
|
H2RA |
Anti-ulcer |
|
|
UrinaryTract Antispasmodics |
Urinary Incontinence |
|
|
*COX-2 Inhibitor |
Arthritis |
|
|
|
Month of Review |
Medication Use |
Date for PhRMA Submission |
Alaska Medicaid P&T Meeting |
All classes are being re-reviewed unless noted with an asterisk * |
January 2008 |
|
December 10, 2007 |
January 18, 2008 |
* Benzoyl Peroxide / Clindamycin Combos |
Acne |
|
|
* Renin Inhibitors |
High blood pressure |
|
|
ACE |
High blood pressure |
|
|
ARB |
High blood pressure |
|
|
CCB |
High blood pressure |
|
|
Topical Iimmunomodulators |
Skin rash |
|
|
Oral Beta Blockers |
Heart & blood pressure |
|
|
Sulfonylureas |
Diabetes |
|
|
Insulins |
Diabetes |
|
|
TZDs |
Diabetes |
|
|
Biguanides |
Diabetes |
|
|
Metglinides |
Diabetes |
|
|
Incretin Mimetics |
Diabetes |
|
|
Alpha Glucosidase Inhibitor |
Diabetes |
|
|
Glaucoma Agents |
Glaucoma |
|
|
|
Month of Review |
Medication Use |
Date for PhRMA Submission |
Alaska Medicaid
P&T Meeting |
All classes are being re-reviewed unless noted with an asterisk * |
April 2008 |
|
|
|
* Low-sedating Antihistamines |
Anti-allergy |
|
|
* Otic Quinolones |
Antibiotics for ears |
|
|
Anti-emetic |
Anti-nauseant |
|
|
Anti-migraine |
Anti-migraine |
|
|
Nasal Steroids |
Anti-allergy |
|
|
Leukotriene Inhibitors |
Asthma |
|
|
Inhaled Steroids |
Asthma |
|
|
Short Acting Beta Agonists |
Asthma |
|
|
Long Acting Beta Agonists |
Asthma |
|
|
COPD Inhalant Drugs |
COPD |
|
|
2nd & 3rd Generation Cephlasporins |
Antibiotics |
|
|
2nd & 3rd Generation Quinolones |
Antibiotics |
|
|
Ophthalmic Anti-allergy
Agents |
Anti-allergy for eyes |
|
|
Ophthalmic Mast Cell Stablizers |
Anti-allergy for eyes |
|
|
Ophthalmic Quinolones |
Antibiotics for the eyes |
|
|
Ophthalmic
Immunomodulator |
Dry eyes |
|
|
Hepatitis C |
Hepatitis C Medications |
|
|
Anti-herpes |
Genital Herpes, Shingles |
|
|
Anti-fungal - Onychomycosis |
Nail Fungus |
|
|
|
|
| P&T Meeting #24: May 18, 2007 |
Drug Class Review |
Common Drug Names |
Drug Classes Posted to website |
Date for Pharma Clinical Submissions |
Alaska P&T Meeting |
| Re-review Leukotriene Inhibitor |
Asthma |
|
4/23/2007 |
|
| Re-review Nasal Steroids |
Asthma |
| Re-review Inhalant Steroids |
Asthma |
| Re-review short acting B2 Agonists |
Asthma |
| Re-review long acting B2 Agonists |
Asthma |
Re-review COP
inhalant drugs |
Medication to improve breathing
in COPD |
| Re-review Antifungals |
Anti-fungal |
| Re-review Antivirals |
Anti-viral |
Re-review Cephalsporins
2nd & 3rd generation |
Antibiotic |
Re-review Quinolones
2nd & 3rd generation |
Antibiotic |
| Re-review Hepatitis C drugs |
Hepatitis C drug |
| P&T Meeting #23: April 20, 2007 |
Drug Class Review |
Common Drug Names |
Drug Classes Posted to website |
Date for Pharma Clinical Submissions |
Alaska P&T Meeting |
| Initial Review Incretin Mimetics |
Diabetes Medication |
|
3/26/2007 |
|
| Re-review Alpha Glucosidase Inhibitors |
Diabetes Medication |
| Re-review Biguanides |
Diabetes Medication |
| Re-review Metiglinides |
Diabetes Medication |
| Re-review Sulfonylureas |
Diabetes Medication |
| Re-review Insulins |
Diabetes Medication |
| Re-review Thiazolidinedione |
Diabetes Medication |
| Re-review of Glaucoma agents |
Glaucoma Medication |
| P&T Meeting #22: February 16, 2007 |
Drug Class Review |
Common Drug Names |
Drug Classes Posted to website |
Date for Pharma Clinical Submissions |
Alaska P&T Meeting |
| Re-review ACE |
High Blood Pressure |
|
1/22/2007 |
|
| Re-review ARB |
High Blood Pressure |
| Re-review Calcium Channel Blockers - all different ones |
High Blood Pressure |
Dihydropyridine |
High Blood Pressure |
Non-dihydropyridine |
High Blood Pressure |
Phenylalkylamine |
High Blood Pressure |
| Re-review Oral Beta-blockers |
Heart & High Blood Pressure |
| P&T Meeting #21: January 19, 2007 |
Drug Class Review |
Common Drug Names |
Drug Classes Posted to website |
Date for Pharma Clinical Submissions |
Alaska P&T Meeting |
Re-review Anti-emetic |
Anti-nausea |
|
12/22/2006 |
|
Re-review Anti-migraine |
Anti-migraine |
Re-review topical immunomodulators |
Skin Rashes |
Re-review urinary track antispasmodics |
Urinary Incontinence |
Re-review PPI's |
Anti-ulcer |
Re-review Anti-Tumor
Necrosis Factor |
Rheumatoid Arthritis |
Re-review H2RA |
Anti-ulcer |
| P&T Meeting #20: November 17, 2006 |
Drug Class Review |
Common Drug Names |
Drug Classes Posted to website |
Date for Pharma Clinical Submissions |
Alaska P&T Meeting |
Re-review Other Antidepressants
|
Antidepressant |
|
10/23/2006 |
|
Re-review Ophthalmic Immunomodulator |
Dry Eyes |
Re-review Non-Ergot
Dopamine receptors |
Parkinson's Disease |
Re-review Ophthalmic antihistamines |
Eye Drops for Allergy |
Re-review Ophthalmic
Mast Cell Stablizers |
Eye Drops for Allergy |
Re-review Ophthalmic Quinolones |
Antibiotic Eye Drops |
Re-review Multiple
Sclerosis Drugs |
Multiple Sclerosis |
Re-review Cholinesterase Inhibitor - Alzheimer |
Alzheimer Medications |
| P&T Meeting #19: October 13, 2006 |
Drug Class Review |
Common Drug Names |
Drug Classes Posted to website |
Date for Pharma Clinical Submissions |
Alaska P&T Meeting |
Re-review ADD / ADHD |
Attention Deficit Hyperactive Disorder |
|
9/18/2006 |
|
Re-review Sedative Hypnotics |
Sleeping Aid |
Re-review SSRIs |
Antidepressant |
Anticonvulsants,
1st Generation |
Anti-seizure |
Anticonvulsants,
2nd Generation |
Anti-seizure |
| P&T Meeting #18: September 15, 2006 |
Drug Class Review |
Common Drug Names |
Drug Classes Posted to website |
Date for Pharma Clinical Submissions |
Alaska P&T Meeting |
Re-review Alpha Blockers |
High Blood Pressure & Prostate Medications |
|
08/18/06 |
|
Re-review Androgen
Hormone inhibitor |
Prostate Medications |
Re-review Electrolyte
Depletors |
Renal Disease Drugs |
Re-review Lipotropics
- Fibric Acid |
Cholesterol Medications |
Re-review Lipotropics
- Niacin |
Cholesterol Medications |
Re-review Statins |
Cholesterol Medications |
Re-review Opioids, Long Acting |
Chronic Pain Medications |
Re-review Bisphosphates |
Osteoporosis Medication |
| P&T Meeting #17: May 19, 2006 |
Drug Class Review |
Common Drug Names |
Drug Classes Posted to website |
Date for Pharma Clinical Submissions |
Alaska P&T Meeting |
| Re-review Leukotriene Inhibitor |
Asthma Medication |
|
4/28/2006
|
5/19/2006
|
| Re-review Nasal Steroids |
Asthma Medication |
| Re-review Inhalant Steroids |
Asthma Medication |
Re-review short acting
B2 Agonists |
Asthma Medication |
Re-review long acting
B2 Agonists |
Asthma Medication |
| Re-review Antifungals |
Antibiotics |
| Re-review Antivirals |
Antiviral Medication |
Re-review Cephalsporins
2nd generation |
Antibiotics |
Re-review Cephalosporins
3rd generation |
Antibiotics |
Re-review Quinolones
2nd generation |
Antibiotics |
Re-review Quinolones
3rd generation |
Antibiotics |
| Re-review Hep C drugs |
Hepatitis C Medications |
| Re-review Macrolides |
Antibiotics |
Preferred Drug List Program (PDL)